Back To TopGet Opthea Updates

Dr. Han’s career in biotechnology and pharmaceutical industry spans over 25 years, with 19 years in ophthalmology.  He brings experience in early and late-stage drug development in both anterior and posterior ophthalmology.    He has a proven track record of success in supporting several product launches, including launch of Eylea for multiple retinal indications.  

Recently, Dr. Han held the position as Vice President of Medical Affairs at Adverum.  He has held various prominent leadership positions in the industry as well as in pharmacy practice.  Industry experience spans various therapeutic areas in ophthalmology, oncology, cardiology, and metabolism, working with small molecules, biologics, and gene therapies.  Prior experience includes work at Regeneron, Amgen, Chiron, and Bayer.  He also served as a faculty member in academia.  

Dr. Han holds a PharmD from University of California San Francisco School of Pharmacy and a graduate from University of California Berkeley in Immunology and Microbiology.